Page last updated: 2024-12-06
irtemazole
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Description
irtemazole: MF C18-H16-N4 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 71330 |
| CHEMBL ID | 2105112 |
| SCHEMBL ID | 636285 |
| MeSH ID | M0168962 |
Synonyms (41)
| Synonym |
|---|
| irtemazolum |
| irtemazol |
| irtemazole [usan:inn:ban] |
| aak27wy74i , |
| unii-aak27wy74i |
| 1h-benzimidazole, 5-(1h-imidazol-1-ylphenylmethyl)-2-methyl-, (+-)- |
| (+-)-5-(alpha-imidazol-1-ylbenzyl)-2-methylbenzimidazole |
| irtemazolum [inn-latin] |
| r 60844 |
| irtemazol [inn-spanish] |
| irtemazole |
| r-60844 |
| D04617 |
| irtemazole (usan/inn) |
| 115574-30-6 |
| 6-[imidazol-1-yl(phenyl)methyl]-2-methyl-1h-benzimidazole |
| r60844 |
| CHEMBL2105112 |
| SCHEMBL636285 |
| 1h-benzimidazole, 5-(1h-imidazol-1-ylphenylmethyl)-2-methyl-, (+/-)- |
| irtemazole [usan] |
| irtemazole [inn] |
| (+/-)-5-(.alpha.-imidazol-1-ylbenzyl)-2-methylbenzimidazole |
| 1h-benzimidazole, 5-(1h-imidazol-1-ylphenylmethyl)-2-methyl- |
| 1h-benzimidazole, 6-(1h-imidazol-1-ylphenylmethyl)-2-methyl- |
| AKOS030530803 |
| 129369-64-8 |
| unii-zpe7cm7fng |
| unii-bz8gv6sk6h |
| 5-((1h-imidazol-1-yl)(phenyl)methyl)-2-methyl-1h-benzo[d]imidazole |
| irtemazole, (-)- |
| 115576-85-7 |
| 1h-benzimidazole, 5-(1h-imidazol-1-ylphenylmethyl)-2-methyl-, (+)- |
| 1h-benzimidazole, 5-(1h-imidazol-1-ylphenylmethyl)-2-methyl-, (-)- |
| ZPE7CM7FNG , |
| irtemazole, (+)- |
| 115576-86-8 |
| BZ8GV6SK6H , |
| Q27273833 |
| DTXSID80869596 |
| 6-[(1h-imidazol-1-yl)(phenyl)methyl]-2-methyl-1h-benzimidazole |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 1 (14.29%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (85.71%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||